Helping to share the web since 1996

Pfizer Claims : Antiviral Pill Paxlovid is Effective against all variants of Covid-19

US-American Pharmaceutical Company Pfizer says that its antiviral Paxlovid drug is effective against the Omicron variant of Covid-19. The company made this claim by releasing 3 lab study reports. However, these reports are yet to be reviewed.

‘Effective against all variants of Corona’

According to Pfizer, studies have shown that the drug Paxlovid has the ability to stop Omicron from replicating in cells. This medicine maintains plasma concentration many times higher than required. Pfizer’s Chief Scientific Officer Mikel Dolston said, “We have designed PaxLovid against all variants of the coronavirus.

‘Reduces the risk of death by 90 percent’

He said, the data has shown that our oral (taken by mouth) Covid-19 therapy can be an important tool in the fight against this corona virus and Omicron variants. Clinical trials have shown that taking Paxlovid medicine within 5 days of the onset of symptoms of corona reduces the risk of hospitalisation or death by about 90 percent.

‘A total of 30 tablets will come’

Mikel Dolston said that a set of 30 tablets of Paxlovid will come for the patient. 3 tablets to be taken 2 times a day for five consecutive days. These 3 tablets will consist of 2 tablets of Nirmatrelvir and 1 tablet of Ritonavir. It contains Nirmatrelavir, which inhibits a SARS-CoV-2 protein to prevent the virus from replicating. At the same time, ritonavir slows down the breakdown of nirmatrelvir in the body.

Pfizer claims that more than 90 percent of corona patients who took its antiviral drug Paxlovid during the trial saw significant improvement within 3 days.

back to news headlines